+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Biopharmaceutical Bioseparation Systems - Global Market Trajectory & Analytics

  • ID: 3619380
  • Report
  • February 2022
  • Region: Global
  • 313 Pages
  • Global Industry Analysts, Inc

FEATURED COMPANIES

  • 3M Company
  • 3M Purification, Inc.
  • Konik Nanobiotech SL
  • Liminal BioSciences Inc.
  • Merck KGaA
  • Pall Corporation

Global Biopharmaceutical Bioseparation Systems Market to Reach $14 Billion by 2026


Bioseparation refers to the practice of purification and separation of biological products. Biological agents like biological membranes, enzymes and plants are used for large-scale purification of biological products based on engineering and scientific principles. Depending upon the various characteristics, such as volatility, solubility, density, size, electrostatic charge, diffusivity, shape, polarity, and electrostatic charge, the biological products are separated as well as purified using a bioseparation technique. Increasing demand for biological pharmaceuticals, emergence of new biologics such as vaccines and monoclonal antibodies, and advent of biosimilars or generic biological drugs are driving the production of these drugs, in turn driving the demand for bioseparation systems used in their manufacturing.

Bioprocessing represents an expensive, complex and time-consuming step in the production of biopharmaceutical drugs. Designing downstream processing presents significant challenges, as characterizing the identity and structure as well as measuring targeted components is innately difficult. Development of biological drugs takes several years leaving limited time on market for these drugs to gain returns on investments. Consequently, there is a growing emphasis on evolution of technologies in this area to reduce expenses and make them more efficient.

Amid the COVID-19 crisis, the global market for Biopharmaceutical Bioseparation Systems estimated at US$8.5 Billion in the year 2020, is projected to reach a revised size of US$14 Billion by 2026, growing at a CAGR of 8.6% over the analysis period. Chromatography, one of the segments analyzed in the report, is projected to grow at a 8.1% CAGR to reach US$7.6 Billion by the end of the analysis period. After a thorough analysis of the business implications of the pandemic and its induced economic crisis, growth in the Other Technologies segment is readjusted to a revised 9.1% CAGR for the next 7-year period. This segment currently accounts for a 47.8% share of the global Biopharmaceutical Bioseparation Systems market.



The U.S. Market is Estimated at $4.1 Billion in 2021, While China is Forecast to Reach $1.4 Billion by 2026


The Biopharmaceutical Bioseparation Systems market in the U.S. is estimated at US$4.1 Billion in the year 2021. The country currently accounts for a 44.67% share in the global market. China, the world second largest economy, is forecast to reach an estimated market size of US$1.4 Billion in the year 2026 trailing a CAGR of 11% through the analysis period. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 7% and 7.4% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 7.8% CAGR while Rest of European market (as defined in the study) will reach US$1.6 Billion by the close of the analysis period.

The market is forecast to grow rapidly in the imminent future, driven by the continuous modification of traditional separation methods, as well as availability of new technologies. Chromatography systems, centrifuges, membrane/filters, and other forms of bioseparation systems are used for separation of biological products, such as biopharmaceuticals. Factors such as growing biopharmaceuticals demand, technological advancements in terms of equipment, and government initiatives aimed at increasing awareness are propelling growth in the global bioseparation systems market. Additionally, the growing use of single-use/disposable instruments spurred by slew of regulations and increasing focus on production efficiency and product quality are driving growth in the market. An example is the disposable continuous chromatography. Such single-use systems are designed to be more precise and enable more accurate analysis of data. Furthermore, the new and more efficient systems are also cost effective in addition to being reliable and featuring better functionalities.

The development of advanced therapeutics is also creating a favorable scenario for demand growth of separation systems. Developments, such as HBs-AG generated by heterologous-expression in yeasts, the first-of-its-kind inhalable insulin powder meant for diabetics, and such others are expected to drive further market growth. Research is also ongoing for the development of recombinant-fusion protein markers targeting infectious diseases. Researchers are trying to identify the impact of host-cell protein in the production of recombinant protein and are also focused on identification and characterization of cold-active enzymes, which have significant potential for several commercial applications, particularly food processing. These and many such innovations that are currently underway are expected to present significant growth opportunities for the bioseparation market in the coming years. Furthermore, growing demand for cell-based therapies and personalized medicines would also create strong demand for bioseparation techniques in the years ahead. These factors would result in increased adoption of novel technology-based bioseparation systems for large scale downstream-processing.

Select Competitors (Total 52 Featured) -

  • 3M Company
  • 3M Purification, Inc.
  • Agilent Technologies, Inc.
  • Alfa Wassermann Separation Technologies, LLC
  • Flottweg Separation Technology
  • GEA Westfalia Separator Group GmbH
  • GE Healthcare Life Sciences
  • KNAUER Wissenschaftliche Geräte GmbH
  • Konik Nanobiotech SL
  • Merck KGaA
  • Pall Corporation
  • Liminal BioSciences Inc.
  • Sartorius Stedim Biotech
  • Repligen Corporation
  • Thermo Fisher Scientific, Inc.
  • Tosoh Bioscience, Inc.
  • YMC Europe GmbH
Frequently Asked Questions about the Global Market for Biopharmaceutical Bioseparation Systems

What is the estimated value of the Global Market for Biopharmaceutical Bioseparation Systems?

The Global Market for Biopharmaceutical Bioseparation Systems was estimated to be valued at $8.5 Billion in 2020.

What is the growth rate of the Global Market for Biopharmaceutical Bioseparation Systems?

The growth rate of the Global Market for Biopharmaceutical Bioseparation Systems is 8.7%, with an estimated value of $14.0 Billion by 2026.

What is the forecasted size of the Global Market for Biopharmaceutical Bioseparation Systems?

The Global Market for Biopharmaceutical Bioseparation Systems is estimated to be worth $14.0 Billion by 2026.

Who are the key companies in the Global Market for Biopharmaceutical Bioseparation Systems?

Key companies in the Global Market for Biopharmaceutical Bioseparation Systems include 3M Company, 3M Purification, Inc., Agilent Technologies, Inc., Alfa Wassermann Separation Technologies, LLC, Flottweg Separation Technology, GEA Westfalia Separator Group GmbH, GE Healthcare Life Sciences, KNAUER Wissenschaftliche Geräte GmbH and Merck KGaA.
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • 3M Company
  • 3M Purification, Inc.
  • Konik Nanobiotech SL
  • Liminal BioSciences Inc.
  • Merck KGaA
  • Pall Corporation

I. METHODOLOGY


II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

  • Impact of Covid-19 and a Looming Global Recession
  • 2020 Marked as a Year of Disruption & Transformation
  • The Race Between the Virus & Vaccines Intensifies. Amidst this Chaotic Battle, Where is the World Economy Headed in 2021?
  • How Fast the World is Vaccinated Will Determine How Soon the Pandemic Will End: Global Number of Annual COVID-19 Vaccine Doses (In Million) for Years 2020 through 2025 by Geographic Region/Country
  • Progress on Vaccinations, Why Should Businesses Care?
  • These are Times When Questions Abound & Answers Are Few
  • With IMF’s Upward Revision of Global GDP Forecasts for 2021, Most Companies Are Bullish About a Global Economic Comeback.
  • A Strong 2021 Economic Rebound Based On Pent-Up Demand Comes as a Relief for Suffering Industries & Markets: World Economic Growth Projections (Real GDP, Annual % Change) for 2020 through 2022
  • How the Healthcare Industry Has & Continues to be Impacted by the Pandemic & What’s the New Normal?
  • With the COVID-19 Pandemic Exposing Global Healthcare Unpreparedness, There is Increasing Policy Led Focus on Rebooting Health Systems Worldwide: Current & Required Healthcare Spending as % of GDP
  • Impact of COVID-19 on Bioseparation Market
  • Scope of Affinity Chromatography in Aiding the Vaccine Purification methodology
  • Biopharmaceutical Bioseparation Systems – Global Key Competitors Percentage Market Share in 2022 (E)
  • A Prelude to Biopharmaceutical Bioseparation Systems
  • A Peek into Biopharmaceutical Manufacturing
  • Downstream Processing of Biosynthetic Products – An Overview
  • Bioseparation Systems – Invaluable Tools in Biopharmaceutical Manufacturing
  • US Remains Market Leader; Developing Countries to Drive Market Growth
  • Chromatography Leads the Pack
  • Competition
  • Leading Players in the Global Biopharmaceutical Bioseparation Systems Market (2020): Percentage Market Share Breakdown of Revenues
  • Recent Market Activity
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

  • Growing Biopharmaceutical Market Drives Demand for Bioseparation Systems
  • Top 10 Biopharmaceutical Companies: 2019
  • Biological License Application (BLA) Approvals-2021
  • Biological License Application (BLA) Approvals-2020
  • Biological License Application (BLA) Approvals: 2019
  • Growing Biosimilars Market – A Clear Advantage for Bioseparation Technologies
  • Patent Expiries of Major Biopharmaceutical Drugs in the US and Europe
  • Progressive Regulatory Framework Accelerates Product Approvals & Subsequently Market Revenues
  • Specific Guidelines for Biosimilars in Various Countries with Year of Publication
  • Biosimilars Regulatory Agencies in Select Regional Markets
  • Biosimilar Approvals in the US (as of February 2021)
  • Biosimilar Approvals in Europe (as of January 2021)
  • High Demand for Monoclonal Antibodies Generates Significant Opportunities for Bioseparation Systems
  • Downstream Processing – A Major Trend among Biopharmaceutical Manufacturers
  • Chromatography – The Gold Standard Separation Technology
  • Global Chromatography Market (2020): Percentage Share Breakdown of Value Sales by Chromatography Techniques for Gas Chromatography, Liquid Chromatography, Supercritical Fluid Chromatography, Thin Layer Chromatography, and Others
  • Increasing Demand for Gas Chromatography in Biopharma Separation
  • Superior Efficiency Drives Use of Synthetic Ligands in Affinity Chromatography
  • A Comparison of Protein and Synthetic Ligands
  • Pre-packed Disposable Columns in Chromatography Gain Attention
  • SMBC – An Old Approach Gaining Significant Attention
  • Major Advantages and Disadvantages of SMBC
  • Twin-Column SMB – An Emerging Alternative to Protein A Columns
  • Growing Focus on Alternatives to Protein A Chromatography
  • Chiral Chromatography Increases in Popularity
  • Chromatography Efficiency and Selectivity
  • Mixed-Mode Chromatography
  • Multimode Chromatography
  • Mixed-Mode and Multimode Media Offer Cost Savings
  • Flexible and Selective Chromatography Improves Biopharmaceutical Efficiencies
  • Inherent Benefits of Membrane Chromatography to Drive its Use in Bioprocessing
  • His-tagged purification of protein & Immobilized Metal Affinity Chromatography (IMAC)
  • Growing Use of Membrane Filtration in Biopharmaceutical Manufacturing
  • Downstream Production of Biopharmaceuticals: Filtration Challenges
  • Evolving Membrane Functions in Filtration for the Production of mAbs
  • Filtration Technology: The Future
  • Membrane Adsorbers Gain Ground in Biopharmaceutical Downstream Purification
  • Prospering Vaccine Market Drives Use of Ultrafiltration Techniques
  • Membrane & Bioseparation
  • Hand-powered Centrifuge setup can Diagnose Covid-19 for just a dollar a test
  • Cell Disruption & Methods Gain Popularity
  • Advent of Innovative Technologies Streamline and Enhance Production of Biopharmaceutical Systems
  • Introduction of Integrated Continuous Bioprocessing System Improves Productivity and Minimizes Raw Material Wastage
  • Use of Continuous Processing Technique for Manufacturing Life-Saving Medicines Gains Momentum
  • Demand for Sustainable Nanofiber Chromatography Mechanism Witnesses an Upward Momentum
  • Use of Precipitation Technique for Purifying Therapeutic Proteins Exhibits a Surge
  • Continuous Bioseparation Gains Momentum
  • Single-Use Systems Play a Key Role
  • Minimizing Centrifugation Steps
  • Single-Use Disposable Technologies Gain Attention
  • Increase in Healthcare Spending Stirs Demand for Biopharmaceutical Bioseperation Systems
  • World Healthcare Expenditure (In US$ Billion) for the Years 2017-2023
  • Growing Preference for Personalized Medicine to Drive Market Growth
  • Global Personalized Medicine Market: Revenues in US$ Million for the Years 2019, 2021, 2023 and 2025

4. GLOBAL MARKET PERSPECTIVE

TABLE 1: World Recent Past, Current & Future Analysis for Biopharmaceutical Bioseparation Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2020 through 2027 and % CAGR
TABLE 2: World Historic Review for Biopharmaceutical Bioseparation Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 3: World 15-Year Perspective for Biopharmaceutical Bioseparation Systems by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2012, 2021 & 2027
TABLE 4: World Recent Past, Current & Future Analysis for Chromatography by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2020 through 2027 and % CAGR
TABLE 5: World Historic Review for Chromatography by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 6: World 15-Year Perspective for Chromatography by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027
TABLE 7: World Recent Past, Current & Future Analysis for Other Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2020 through 2027 and % CAGR
TABLE 8: World Historic Review for Other Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 9: World 15-Year Perspective for Other Technologies by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027

III. MARKET ANALYSIS

UNITED STATES

  • Biopharmaceutical Bioseparation Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2022 (E)
TABLE 10: USA Recent Past, Current & Future Analysis for Biopharmaceutical Bioseparation Systems by Technology - Chromatography and Other Technologies - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 11: USA Historic Review for Biopharmaceutical Bioseparation Systems by Technology - Chromatography and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 12: USA 15-Year Perspective for Biopharmaceutical Bioseparation Systems by Technology - Percentage Breakdown of Value Revenues for Chromatography and Other Technologies for the Years 2012, 2021 & 2027

CANADA

TABLE 13: Canada Recent Past, Current & Future Analysis for Biopharmaceutical Bioseparation Systems by Technology - Chromatography and Other Technologies - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 14: Canada Historic Review for Biopharmaceutical Bioseparation Systems by Technology - Chromatography and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 15: Canada 15-Year Perspective for Biopharmaceutical Bioseparation Systems by Technology - Percentage Breakdown of Value Revenues for Chromatography and Other Technologies for the Years 2012, 2021 & 2027

JAPAN

  • Biopharmaceutical Bioseparation Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2022 (E)
TABLE 16: Japan Recent Past, Current & Future Analysis for Biopharmaceutical Bioseparation Systems by Technology - Chromatography and Other Technologies - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 17: Japan Historic Review for Biopharmaceutical Bioseparation Systems by Technology - Chromatography and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 18: Japan 15-Year Perspective for Biopharmaceutical Bioseparation Systems by Technology - Percentage Breakdown of Value Revenues for Chromatography and Other Technologies for the Years 2012, 2021 & 2027

CHINA

  • Biopharmaceutical Bioseparation Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2022 (E)
TABLE 19: China Recent Past, Current & Future Analysis for Biopharmaceutical Bioseparation Systems by Technology - Chromatography and Other Technologies - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 20: China Historic Review for Biopharmaceutical Bioseparation Systems by Technology - Chromatography and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 21: China 15-Year Perspective for Biopharmaceutical Bioseparation Systems by Technology - Percentage Breakdown of Value Revenues for Chromatography and Other Technologies for the Years 2012, 2021 & 2027

EUROPE

  • Biopharmaceutical Bioseparation Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2022 (E)
TABLE 22: Europe Recent Past, Current & Future Analysis for Biopharmaceutical Bioseparation Systems by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2020 through 2027 and % CAGR
TABLE 23: Europe Historic Review for Biopharmaceutical Bioseparation Systems by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 24: Europe 15-Year Perspective for Biopharmaceutical Bioseparation Systems by Geographic Region - Percentage Breakdown of Value Revenues for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2012, 2021 & 2027
TABLE 25: Europe Recent Past, Current & Future Analysis for Biopharmaceutical Bioseparation Systems by Technology - Chromatography and Other Technologies - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 26: Europe Historic Review for Biopharmaceutical Bioseparation Systems by Technology - Chromatography and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 27: Europe 15-Year Perspective for Biopharmaceutical Bioseparation Systems by Technology - Percentage Breakdown of Value Revenues for Chromatography and Other Technologies for the Years 2012, 2021 & 2027

FRANCE

  • Biopharmaceutical Bioseparation Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2022 (E)
TABLE 28: France Recent Past, Current & Future Analysis for Biopharmaceutical Bioseparation Systems by Technology - Chromatography and Other Technologies - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 29: France Historic Review for Biopharmaceutical Bioseparation Systems by Technology - Chromatography and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 30: France 15-Year Perspective for Biopharmaceutical Bioseparation Systems by Technology - Percentage Breakdown of Value Revenues for Chromatography and Other Technologies for the Years 2012, 2021 & 2027

GERMANY

  • Biopharmaceutical Bioseparation Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2022 (E)
TABLE 31: Germany Recent Past, Current & Future Analysis for Biopharmaceutical Bioseparation Systems by Technology - Chromatography and Other Technologies - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 32: Germany Historic Review for Biopharmaceutical Bioseparation Systems by Technology - Chromatography and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 33: Germany 15-Year Perspective for Biopharmaceutical Bioseparation Systems by Technology - Percentage Breakdown of Value Revenues for Chromatography and Other Technologies for the Years 2012, 2021 & 2027

ITALY

TABLE 34: Italy Recent Past, Current & Future Analysis for Biopharmaceutical Bioseparation Systems by Technology - Chromatography and Other Technologies - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 35: Italy Historic Review for Biopharmaceutical Bioseparation Systems by Technology - Chromatography and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 36: Italy 15-Year Perspective for Biopharmaceutical Bioseparation Systems by Technology - Percentage Breakdown of Value Revenues for Chromatography and Other Technologies for the Years 2012, 2021 & 2027

UNITED KINGDOM

  • Biopharmaceutical Bioseparation Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2022 (E)
TABLE 37: UK Recent Past, Current & Future Analysis for Biopharmaceutical Bioseparation Systems by Technology - Chromatography and Other Technologies - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 38: UK Historic Review for Biopharmaceutical Bioseparation Systems by Technology - Chromatography and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 39: UK 15-Year Perspective for Biopharmaceutical Bioseparation Systems by Technology - Percentage Breakdown of Value Revenues for Chromatography and Other Technologies for the Years 2012, 2021 & 2027

SPAIN

TABLE 40: Spain Recent Past, Current & Future Analysis for Biopharmaceutical Bioseparation Systems by Technology - Chromatography and Other Technologies - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 41: Spain Historic Review for Biopharmaceutical Bioseparation Systems by Technology - Chromatography and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 42: Spain 15-Year Perspective for Biopharmaceutical Bioseparation Systems by Technology - Percentage Breakdown of Value Revenues for Chromatography and Other Technologies for the Years 2012, 2021 & 2027

RUSSIA

TABLE 43: Russia Recent Past, Current & Future Analysis for Biopharmaceutical Bioseparation Systems by Technology - Chromatography and Other Technologies - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 44: Russia Historic Review for Biopharmaceutical Bioseparation Systems by Technology - Chromatography and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 45: Russia 15-Year Perspective for Biopharmaceutical Bioseparation Systems by Technology - Percentage Breakdown of Value Revenues for Chromatography and Other Technologies for the Years 2012, 2021 & 2027

REST OF EUROPE

TABLE 46: Rest of Europe Recent Past, Current & Future Analysis for Biopharmaceutical Bioseparation Systems by Technology - Chromatography and Other Technologies - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 47: Rest of Europe Historic Review for Biopharmaceutical Bioseparation Systems by Technology - Chromatography and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 48: Rest of Europe 15-Year Perspective for Biopharmaceutical Bioseparation Systems by Technology - Percentage Breakdown of Value Revenues for Chromatography and Other Technologies for the Years 2012, 2021 & 2027

ASIA-PACIFIC

  • Biopharmaceutical Bioseparation Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2022 (E)
TABLE 49: Asia-Pacific Recent Past, Current & Future Analysis for Biopharmaceutical Bioseparation Systems by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2020 through 2027 and % CAGR
TABLE 50: Asia-Pacific Historic Review for Biopharmaceutical Bioseparation Systems by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 51: Asia-Pacific 15-Year Perspective for Biopharmaceutical Bioseparation Systems by Geographic Region - Percentage Breakdown of Value Revenues for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2012, 2021 & 2027
TABLE 52: Asia-Pacific Recent Past, Current & Future Analysis for Biopharmaceutical Bioseparation Systems by Technology - Chromatography and Other Technologies - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 53: Asia-Pacific Historic Review for Biopharmaceutical Bioseparation Systems by Technology - Chromatography and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 54: Asia-Pacific 15-Year Perspective for Biopharmaceutical Bioseparation Systems by Technology - Percentage Breakdown of Value Revenues for Chromatography and Other Technologies for the Years 2012, 2021 & 2027

AUSTRALIA

  • Biopharmaceutical Bioseparation Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2022 (E)
TABLE 55: Australia Recent Past, Current & Future Analysis for Biopharmaceutical Bioseparation Systems by Technology - Chromatography and Other Technologies - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 56: Australia Historic Review for Biopharmaceutical Bioseparation Systems by Technology - Chromatography and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 57: Australia 15-Year Perspective for Biopharmaceutical Bioseparation Systems by Technology - Percentage Breakdown of Value Revenues for Chromatography and Other Technologies for the Years 2012, 2021 & 2027

INDIA

  • Biopharmaceutical Bioseparation Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2022 (E)
TABLE 58: India Recent Past, Current & Future Analysis for Biopharmaceutical Bioseparation Systems by Technology - Chromatography and Other Technologies - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 59: India Historic Review for Biopharmaceutical Bioseparation Systems by Technology - Chromatography and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 60: India 15-Year Perspective for Biopharmaceutical Bioseparation Systems by Technology - Percentage Breakdown of Value Revenues for Chromatography and Other Technologies for the Years 2012, 2021 & 2027

SOUTH KOREA

TABLE 61: South Korea Recent Past, Current & Future Analysis for Biopharmaceutical Bioseparation Systems by Technology - Chromatography and Other Technologies - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 62: South Korea Historic Review for Biopharmaceutical Bioseparation Systems by Technology - Chromatography and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 63: South Korea 15-Year Perspective for Biopharmaceutical Bioseparation Systems by Technology - Percentage Breakdown of Value Revenues for Chromatography and Other Technologies for the Years 2012, 2021 & 2027

REST OF ASIA-PACIFIC

TABLE 64: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Biopharmaceutical Bioseparation Systems by Technology - Chromatography and Other Technologies - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 65: Rest of Asia-Pacific Historic Review for Biopharmaceutical Bioseparation Systems by Technology - Chromatography and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 66: Rest of Asia-Pacific 15-Year Perspective for Biopharmaceutical Bioseparation Systems by Technology - Percentage Breakdown of Value Revenues for Chromatography and Other Technologies for the Years 2012, 2021 & 2027

LATIN AMERICA

  • Biopharmaceutical Bioseparation Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2022 (E)
TABLE 67: Latin America Recent Past, Current & Future Analysis for Biopharmaceutical Bioseparation Systems by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2020 through 2027 and % CAGR
TABLE 68: Latin America Historic Review for Biopharmaceutical Bioseparation Systems by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 69: Latin America 15-Year Perspective for Biopharmaceutical Bioseparation Systems by Geographic Region - Percentage Breakdown of Value Revenues for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2012, 2021 & 2027
TABLE 70: Latin America Recent Past, Current & Future Analysis for Biopharmaceutical Bioseparation Systems by Technology - Chromatography and Other Technologies - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 71: Latin America Historic Review for Biopharmaceutical Bioseparation Systems by Technology - Chromatography and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 72: Latin America 15-Year Perspective for Biopharmaceutical Bioseparation Systems by Technology - Percentage Breakdown of Value Revenues for Chromatography and Other Technologies for the Years 2012, 2021 & 2027

ARGENTINA

TABLE 73: Argentina Recent Past, Current & Future Analysis for Biopharmaceutical Bioseparation Systems by Technology - Chromatography and Other Technologies - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 74: Argentina Historic Review for Biopharmaceutical Bioseparation Systems by Technology - Chromatography and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 75: Argentina 15-Year Perspective for Biopharmaceutical Bioseparation Systems by Technology - Percentage Breakdown of Value Revenues for Chromatography and Other Technologies for the Years 2012, 2021 & 2027

BRAZIL

TABLE 76: Brazil Recent Past, Current & Future Analysis for Biopharmaceutical Bioseparation Systems by Technology - Chromatography and Other Technologies - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 77: Brazil Historic Review for Biopharmaceutical Bioseparation Systems by Technology - Chromatography and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 78: Brazil 15-Year Perspective for Biopharmaceutical Bioseparation Systems by Technology - Percentage Breakdown of Value Revenues for Chromatography and Other Technologies for the Years 2012, 2021 & 2027

MEXICO

TABLE 79: Mexico Recent Past, Current & Future Analysis for Biopharmaceutical Bioseparation Systems by Technology - Chromatography and Other Technologies - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 80: Mexico Historic Review for Biopharmaceutical Bioseparation Systems by Technology - Chromatography and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 81: Mexico 15-Year Perspective for Biopharmaceutical Bioseparation Systems by Technology - Percentage Breakdown of Value Revenues for Chromatography and Other Technologies for the Years 2012, 2021 & 2027

REST OF LATIN AMERICA

TABLE 82: Rest of Latin America Recent Past, Current & Future Analysis for Biopharmaceutical Bioseparation Systems by Technology - Chromatography and Other Technologies - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 83: Rest of Latin America Historic Review for Biopharmaceutical Bioseparation Systems by Technology - Chromatography and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 84: Rest of Latin America 15-Year Perspective for Biopharmaceutical Bioseparation Systems by Technology - Percentage Breakdown of Value Revenues for Chromatography and Other Technologies for the Years 2012, 2021 & 2027

MIDDLE EAST

  • Biopharmaceutical Bioseparation Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2022 (E)
TABLE 85: Middle East Recent Past, Current & Future Analysis for Biopharmaceutical Bioseparation Systems by Technology - Chromatography and Other Technologies - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 86: Middle East Historic Review for Biopharmaceutical Bioseparation Systems by Technology - Chromatography and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 87: Middle East 15-Year Perspective for Biopharmaceutical Bioseparation Systems by Technology - Percentage Breakdown of Value Revenues for Chromatography and Other Technologies for the Years 2012, 2021 & 2027

AFRICA

  • Biopharmaceutical Bioseparation Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2022 (E)
TABLE 88: Africa Recent Past, Current & Future Analysis for Biopharmaceutical Bioseparation Systems by Technology - Chromatography and Other Technologies - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 89: Africa Historic Review for Biopharmaceutical Bioseparation Systems by Technology - Chromatography and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 90: Africa 15-Year Perspective for Biopharmaceutical Bioseparation Systems by Technology - Percentage Breakdown of Value Revenues for Chromatography and Other Technologies for the Years 2012, 2021 & 2027

IV. COMPETITION

  • Total Companies Profiled: 52
Note: Product cover images may vary from those shown

A selection of companies mentioned in this report includes:

  • 3M Company
  • 3M Purification, Inc.
  • Agilent Technologies, Inc.
  • Alfa Wassermann Separation Technologies, LLC
  • Flottweg Separation Technology
  • GEA Westfalia Separator Group GmbH
  • GE Healthcare Life Sciences
  • KNAUER Wissenschaftliche Geräte GmbH
  • Konik Nanobiotech SL
  • Merck KGaA
  • Pall Corporation
  • Liminal BioSciences Inc.
  • Sartorius Stedim Biotech
  • Repligen Corporation
  • Thermo Fisher Scientific, Inc.
  • Tosoh Bioscience, Inc.
  • YMC Europe GmbH
Note: Product cover images may vary from those shown